ICLR Icon Plc

  1. Stocks
  2. Healthcare
  3. NASDAQ: ICLR

Price (delayed)

$163.9

Market cap

$12.65B

P/E Ratio

38.21

Dividend/share

N/A

EPS

$4.29

Enterprise value

$15.21B

?
Relative Growth: Rel. Growth: 18
Relative Strength: Rel. Strength: 71
Relative Valuation: Rel. Valuation: 46
Relative Profitability: Rel. Profitability: 41

ICON Public Limited Company, a contract research organization, provides outsourced development services to the pharmaceutical, biotechnology, and medical device industries in Ireland, rest of Europe, the United States, and internationally. ...

Highlights
The price to earnings (P/E) is 14% lower than the 5-year quarterly average of 45.2 but 9% higher than the last 4 quarters average of 35.7
The net income has plunged by 62% YoY and by 28% from the previous quarter
The EPS has dropped by 59% year-on-year and by 28% since the previous quarter
Sector: Healthcare
Industry: Diagnostics & Research
Website: http://www.iconplc.com
Peers: CRL SCYX

Key stats

What are the main financial stats of ICLR

ICLR stock price

How has the Icon stock price performed over time
Intraday
-1.92%
1 week
-5.77%
1 month
-4.84%
1 year
-3.8%
YTD
-10.05%
QTD
-5.65%

Financial performance

How have Icon's revenue and profit performed over time
Revenue
$8.25B
Gross profit
$1.99B
Operating income
$605.99M
Net income
$328.88M
Gross margin
24.1%
Net margin
4%
The net margin has plunged by 62% YoY and by 29% from the previous quarter
The net income has plunged by 62% YoY and by 28% from the previous quarter
The company's operating margin fell by 45% YoY and by 14% QoQ
The operating income has contracted by 44% YoY and by 13% from the previous quarter

Price vs fundamentals

How does ICLR's price correlate with its fundamentals

Growth

What is Icon's growth rate over time

Valuation

What is Icon stock price valuation
ICLR P/E details
P/E
38.21
P/B
1.34
P/S
1.53
EV/EBIT
24.76
EV/EBITDA
15.45
EV/Sales
1.84
The EPS has dropped by 59% year-on-year and by 28% since the previous quarter
The price to earnings (P/E) is 14% lower than the 5-year quarterly average of 45.2 but 9% higher than the last 4 quarters average of 35.7
The price to book (P/B) is 32% lower than the 5-year quarterly average of 2.0 but 4.6% higher than the last 4 quarters average of 1.3
ICLR's P/S is 35% below its 5-year quarterly average of 2.4 but 4% above its last 4 quarters average of 1.5

Efficiency

How efficient is Icon business performance
The company's return on assets has shrunk by 61% YoY and by 29% QoQ
ICLR's return on equity has dropped by 61% year-on-year and by 29% since the previous quarter
The return on sales has declined by 44% year-on-year and by 14% since the previous quarter
The company's return on invested capital fell by 32% YoY and by 4.7% QoQ

Dividends

What is ICLR's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ICLR.

Financial health

How did Icon financials performed over time
The total assets is 134% more than the total liabilities
Icon's quick ratio has decreased by 26% YoY and by 16% QoQ
Icon's current ratio has decreased by 26% YoY and by 17% from the previous quarter
The debt is 63% less than the equity
The debt to equity has declined by 2.6% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.